Contributions of rare and common variation to early-onset and atypical dementia risk.
Carter A WrightJared W TaylorJesse Nicholas CochranJames M J LawlorBelle A MoyersMichelle D AmaralZachary T BonnstetterPrincess CarterVeronika SolomonRichard M MyersMarissa Natelson LoveDavid S GeldmacherSara J CooperErik D RobersonJ Nicholas CochranPublished in: medRxiv : the preprint server for health sciences (2023)
We collected and analyzed genomic sequencing data from individuals with clinician- diagnosed early-onset or atypical dementia. Thirty-two patients were previously described, with sixty-eight newly described in this report. Of those sixty-eight, sixty-two patients reported Caucasian, non-Hispanic ethnicity and six reported as African American, non-Hispanic. Fifty-three percent of patients had a returnable variant. Five patients harbored a pathogenic variant as defined by the American College of Medical Genetics criteria for pathogenicity. A polygenic risk score was calculated for Alzheimer's patients in the total cohort and compared to the scores of a late-onset Alzheimer's cohort and a control set. Patients with early-onset Alzheimer's had higher non- APOE polygenic risk scores than patients with late onset Alzheimer's, supporting the conclusion that both rare and common genetic variation associate with early-onset neurodegenerative disease risk.